Evidence map›Paper›PMID 34122926›Full record

ArticleChemical science2020

Winning the fight against biofilms: the first six-month study showing no biofilm formation on zwitterionic polyurethanes.

Huifeng Wang, Daniel Edward Christiansen, Shafigh Mehraeen, Gang Cheng

Abstract read
In one paragraph

Article in Chemical science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Huifeng WangDepartment of Chemical Engineering, The University of Illinois at Chicago Chicago IL 60607 USA gancheng@uic.edu https://gancheng.people.uic.edu.
Daniel Edward ChristiansenDepartment of Chemical Engineering, The University of Illinois at Chicago Chicago IL 60607 USA gancheng@uic.edu https://gancheng.people.uic.edu.
Shafigh MehraeenDepartment of Chemical Engineering, The University of Illinois at Chicago Chicago IL 60607 USA gancheng@uic.edu https://gancheng.people.uic.edu.
Gang ChengDepartment of Chemical Engineering, The University of Illinois at Chicago Chicago IL 60607 USA gancheng@uic.edu https://gancheng.people.uic.edu.ORCID https://orcid.org/0000-0002-7170-8968

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biofilms have been a long-standing challenge for healthcare, water transport, and many other industries. They lead to bacterial growth and infections in animals, food products, and humans, cause premature removal of the implanted materials or devices from patients, and facilitate fouling and corrosion of metals. Despite some published and patented methods on minimizing the effects of biofilms for a short period (less than two weeks), there exists no successful means to mitigate or prevent the long-term formation of biofilms. It is even more challenging to integrate critical anti-fouling properties with other needed physical and chemical properties for a range of applications. In this study, we developed a novel approach for combining incompatible, highly polar anti-fouling groups with less polar, mechanically modifying groups into one material. A multifunctional carboxybetaine precursor was designed and introduced into polyurethane. The carboxybetaine precursors undergo rapid, self-catalyzed hydrolysis at the water/material interface and provide critical anti-fouling properties that lead to undetectable bacterial attachment and zero biofilm formation after six months of constant exposure to

Identifiers

PMID34122926
PMCPMC8159170

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.